LBGCX | PMAQX | LBGCX / PMAQX | |
Total Expense Ratio | 1.95 | 0.59 | 331% |
Annual Report Gross Expense Ratio | 2.00 | 0.59 | 339% |
Fund Existence | 15 years | 9 years | - |
Gain YTD | -0.410 | 2.039 | -20% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 273M | 30.6B | 1% |
Annual Yield % from dividends | 0.00 | 0.19 | - |
Returns for 1 year | 14.98 | 10.62 | 141% |
Returns for 3 years | 50.66 | 50.92 | 99% |
Returns for 5 years | 35.44 | 56.82 | 62% |
Returns for 10 years | 54.75 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDNI | 33.29 | N/A | N/A |
First Trust Dow Jones Intl Intnt ETF | |||
IGSB | 52.31 | -0.07 | -0.13% |
iShares 1-5 Year invmt Grd Corp Bd ETF | |||
GTIP | 48.86 | -0.08 | -0.17% |
Goldman Sachs Acs Infl Protd USD Bd ETF | |||
HQL | 12.85 | -0.13 | -1.00% |
abrdn Life Sciences Investors | |||
IAI | 154.06 | -2.25 | -1.44% |
iShares US Broker-Dealers&Secs Exchs ETF |